Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 12,749 Shares

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 12,749 shares of the stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total value of $348,175.19. Following the completion of the transaction, the chief operating officer now directly owns 755,459 shares in the company, valued at $20,631,585.29. The trade was a 1.66 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Evan Roberts also recently made the following trade(s):

• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $48,159.30.
• On Wednesday, January 8th, Evan Roberts sold 2,681 shares of Phreesia stock. The stock was sold at an average price of $27.95, for a total transaction of $74,933.95.
• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $76,450.53.

Phreesia Stock Performance

Shares of PHR opened at $27.26 on Friday. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of -18.55 and a beta of 0.94. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $29.16. The firm has a fifty day simple moving average of $23.87 and a 200 day simple moving average of $22.97. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The company had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The company’s quarterly revenue was up 16.6% on a year-over-year basis. During the same period in the prior year, the business posted ($0.58) EPS. Research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price target on shares of Phreesia in a report on Friday, January 10th. KeyCorp increased their price target on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday, January 8th. Truist Financial raised their price target on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and boosted their price objective for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Finally, Citigroup raised their target price on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a report on Friday, January 10th. Twelve research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $31.00.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Versor Investments LP bought a new stake in shares of Phreesia during the 3rd quarter worth approximately $694,000. Zacks Investment Management bought a new stake in Phreesia during the third quarter worth $631,000. Sei Investments Co. raised its position in Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock worth $3,505,000 after acquiring an additional 95,058 shares in the last quarter. State Street Corp lifted its stake in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after acquiring an additional 88,517 shares during the last quarter. Finally, Barclays PLC grew its position in shares of Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after acquiring an additional 43,225 shares during the period. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.